Bli kund Annonsera
måndag 20 september 2021
Mitt i juridiken
Mitt i juridiken
Läs direkt!

Legal Counsel to Hansa Biopharma

13 september 2021

Hansa Biopharma is a fast-growing biopharmaceutical company that is developing immunomodulatory treatments for enabling transplantations, rare immunoglobulin G (IgG)-mediated autoimmune conditions, gene therapy and cancer.

We are now looking for a legal Counsel that will be part of our legal team at our HQ in Lund.

What you will do:

The Legal Counsel will be reporting to the General Counsel and will be a member of Hansa´s growing Legal & Compliance function. In this, the Legal Counsel will work with the General Counsel, as well as internal and external legal advisors, to support and protect Hansa´s interests. This includes acting as primary support for its platform technology, therapeutic platforms and franchises, providing advice and managing contractual matters for those areas.

The role regularly interacts with the Research and Development function and provides support for other departments and teams as needed. Working in collaboration with internal and external counsel, the Legal Counsel will advise on a variety of issues, including research collaborations, clinical trial agreements, promotional and medical material review, and related legal advice, as well as compliance (in particular data privacy) matters.

The responsibilities in this role includes e.g. acting as a Business Partner in all activities relating to contractual negotiations (including licensing) and company´s statutory obligations; advise on all legal matters related to Hansa´s business activities, including healthcare legislation, data privacy, product liability, securities, and other laws relevant to the commercialization of pharmaceutical products; draft, review and edit business contracts in a multijurisdictional environment; advise on corporate matters; as well as assisting in the development and implementation of company policies and procedures.

Who you are:

You have a Swedish Law Degree (LL.M.) and around three years relevant working experience for the role as in-house counsel and/or from reputable law firms. You have strong knowledge and experience from (bio-)pharma and in advising business stakeholders on legal and compliance issues at all levels of a commercial stage biopharma organization.

You have strong skills in managing cross-functional and/or divisional projects and you are fluent in English and Swedish. If you speak another language such as German or French, that is an advantage. You also have significant experience, and proven ability to effectively engage and manage associates from widely varying backgrounds and functions within a dispersed organization. You are commitment to excellence in all activities and is both pragmatic and goal orientated.

What we offer:

Working at Hansa is more than a job for us. At Hansa, our culture is characterised by pride—pride in what we do, in the company and in what we have, and will, accomplish for patients around the world. We are also proud of our colleagues, and we genuinely care about each other. We are friends, empowering one another and appreciating everyone´s uniqueness, and we believe in working together as a team. We encourage bravery, personal development and discovering new ways forward.

In this role you will be offered a position in a company that envisions a world where patients with rare immunological diseases lead long and healthy lives, the chance to be part of an innovative R&D-driven organisation with a strong desire to make a difference for people; an opportunity to build a fully integrated biopharmaceutical company with global outreach; an open-minded and welcoming atmosphere; as well as friendly, motivated and skilled colleagues with whom you can both laugh and work.

We care about our employees and are immensely proud to have been certified "A Great Place to Work" by Great Place to Work®, a global authority on workplace culture, employee experience and leadership behaviour.

How to apply:

In this recruitment process, Hansa Biopharma is supported by Jurek Law. Interviews will be carried out as applications are received, so please apply as soon as possible via Please note that we do not accept applications via e-mail and your application should be in English. For any questions, please contact recruitment consultant Matilda Karlsson by phone 0736905018 or email

About the Company:

Hansa Biopharma is a fast-growing biopharmaceutical company that is developing immunomodulatory treatments for enabling transplantations, rare immunoglobulin G (IgG)-mediated autoimmune conditions, gene therapy and cancer. The Company´s lead product candidate, imlifidase, has been granted conditional approval in the European Union to desensitise highly sensitised adult kidney transplant patients with a positive crossmatch against an available deceased donor. Commercial launch of imlifidase in select European countries is ongoing. Hansa has established a new function, International Markets, to commercialise markets outside of Europe and in the US.

Hansa´s research and development program is also advancing the Company´s enzyme technology to develop the next generation of IgG-cleaving enzymes with potentially lower immunogenicity, rendering them suitable for repeat dosing in relapsing autoimmune diseases and oncology. Hansa Biopharma is based in Lund, Sweden and has operations in other European countries and the US.

Ny delägare till MAQS

Mikael Satama Granberg blev den 1 september ny delägare vid MAQS Advokatbyrå.

Två nya domare

Regeringen har den 16 september utnämnt en lagman och en chefsrådman.

Ökat anslag till domstolarna

I den nya budgetpropositionen tillförs Sveriges Domstolar 535 miljoner kronor för planeringsperioden 2022-2024 i ökade budgetramar.

Foto Micheal Erhardsson

Riksdagens öppnande

Tisdag den 14 september öppnar Sveriges riksdag och det utgör starten på riksmötet 2021/22.

Hovrätten sänder webbinarier

Hovrätten över Skåne och Blekinge fyller 200 år och bjuder på på åtta webbinarier tillsammans med tingsrätterna i regionen.

Nya domarutnämningar

Regeringen har den 9 september utnämnt en hovrättspresident, två rådmän och tre kammarrättsråd.

Norburg & Scherp rekryterar

Advokaten Helena Selander har anslutit till Norburg & Scherp Advokatbyrå.

Ny delägare i Lindahl

David Ackebo ansluter som delägare i Lindahl och kommer att utveckla verksamheten inom tvistlösning.

Foto Juergen Priewe

Ny domare

Regeringen har den 2 september utnämnt en ny chefsrådman.

Fler brottsmisstänkta unga än äldre

Brå-rapporten avser andel misstänkta för brott bland folkbokförda personer 15 år och äldre med inrikes respektive utrikes bakgrund. Störst andel brottsmisstänkta finns bland inrikesfödda med två utrikesfödda föräldrar.

Kompass nyrekryterar

Kompass Advokat rekryterar Artur Ogelid där han främst ska arbeta med försäkring och finansiell reglering.

Ny delägare till Fylgia

Advokaten Joakim Johansson går in som delägare i Fylgia med tillträde den 1 september. Han kommer närmast från Wistrands advokatbyrå.

300 miljoner satsas inom juridik

Kalmar kommun och Linnéuniversitetet satsar på att juridik ska bli ett utbildnings- och forskningsfält med bas i Kalmar.

InfoTorg - Juridik - Kommentar 6 kommentarer

Foto © tomloel

Nya domarutnämningar

Regeringen har utnämnt sex domare i tingsrätter och kammarrätt.

Ny Säpo-chef

Regeringen har utnämnt Charlotte von Essen till säkerhetspolischef och chef för Säkerhetspolisen.

Ny delägare i Cirio

Den 1 oktober rekryterar Cirio advokatbyrå Hanna Tilus som delägare. Hon kommer att arbeta med life science-bolag och IP-kapacitet.

92 nya advokater

Styrelsen för Sveriges advokatsamfund antog 92 nya ledamöter vid sitt sammanträde den 24 augusti. 47 advokater har lämnat samfundet.

Ny GD för Brottsoffer-myndigheten

Regeringen har utsett Anders Alenskär till generaldirektör för Brottsoffermyndigheten. Han tillträder sin tjänst den 1 november och kommer närmast från en tjänst som lagman vid Lycksele tingsrätt.

Jag vill ha daglig bevakning av juridiska
nyheter från InfoTorg Juridik.
OBS! Om du loggar in kan du lägga upp ett
personligt urval för ditt Nyhetsbrev.
Logga in och lägg upp ett Nyhetsbrev.

» Logga in automatiskt